查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470855

再生医学市场：按类型和应用分类－2024年至2030年全球预测

Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年再生医学市场规模为230.2亿美元，预计2024年将达283.5亿美元，2030年将达到1,024亿美元，复合年增长率为23.76%。

再生医学是一个跨学科领域，应用工程和生命科学原理来促进细胞、组织和器官的再生、修復和替换。我们的目标是透过结合多种方法来恢復受损和患病组织的功能，包括细胞治疗、基因治疗、组织工程以及生物材料和生长因子的应用。这个快速发展的领域有望透过利用人体自身的修復机製或在实验室中创建功能组织来治疗各种医疗状况。再生医学市场的驱动因素包括慢性病和遗传疾病的日益普及、细胞疗法和组织工程的进步以及对研发的重大投资导致突破性治疗方法。此外，世界人口老化和对创新再生治疗的需求也有助于市场扩张。然而，他们面临一些障碍，例如严格的监管政策减缓了核准流程、治疗和研究相关的高成本以及干细胞使用的伦理问题。此外，个人化医疗的进步正在扩大客製化治疗的可能性。新兴市场也提供了新的扩张途径，技术创新不断带来更好的治疗效果，最终可能导致治疗成本降低。

主要市场统计
基准年[2023] 230.2亿美元
预测年份 [2024] 283.5亿美元
预测年份 [2030] 1024亿美元
复合年增长率（%） 23.76%

细胞免疫疗法和细胞治疗产品在个人化治疗的重要应用

再生医学正在透过基于细胞的免疫疗法和细胞治疗产品彻底改变治疗领域。这些先进的治疗方法利用细胞来治疗疾病，包括取自捐赠者并给予多名患者的异体产品，以及取自同一个人并用于治疗的自製产品。基因治疗产品代表了再生医学的重要组成部分，其重点是直接操纵生物体的基因来治疗或预防疾病。这些治疗方法透过引入、移除或改变患者细胞内的遗传物质来纠正遗传异常、表达治疗性蛋白质或禁用故障基因。再生医学的大类包括小分子药物和生技药品。小分子通常是可以调节生物过程的明确的小分子化合物，而生技药品涵盖多种产品，例如抗体、重组蛋白和胜肽。这些药物通常透过影响细胞路径来刺激或诱导再生过程，使它们在修復复杂的组织和器官方面特别有效。组织工程产品开发是再生医学的一个变革领域，旨在修復、替换、维护和增强人体组织。利用支架、细胞和生物活性分子的组织工程方法透过精心设计可与患者组织整合的结构，为器官短缺提供了解决方案，使其比传统移植和重组手术的效果低。

再生医学在应用心血管疾病的重要性日益增加

再生医学透过细胞疗法、组织工程和基因编辑来修復或替换受损的心臟组织，为心血管疾病提供潜在的治疗方法。再生医学在心臟病学中的普及主要是因为它能够最大限度地减少侵入性手术，并有望在心臟衰竭和周边动脉疾病等疾病中实现长期康復。糖尿病影响着全世界数百万人，再生医学透过恢復产生胰岛素的β细胞和再生胰臟组织提供了治疗的潜力。 1 型糖尿病尤其需要这种创新治疗方法，因为自体免疫反应会破坏 β 细胞，并要求患者终生接受胰岛素治疗。肌肉骨骼疾病包括影响骨骼、肌肉和结缔组织的多种疾病。软骨再生和骨骼修復等再生医学应用解决了在损伤后以及骨关节炎等退化性疾病中缩短癒合时间和功能恢復的巨大需求。此外，再生医学可以提供基于细胞的治疗方法和组织工程解决方案，以恢復视力并阻止疾病进展和其他眼科疾病。肿瘤学是再生医学有可能彻底改变癌症治疗的重要领域。透过利用人体自身的治癒机制，它可以刺激免疫系统瞄准并摧毁癌细胞。由于与传统治疗方法相比，此类治疗方法具有个人化性质且副作用较少，因此越来越受到青睐。伤口护理也是医疗保健的重要组成部分，特别是对于因糖尿病或血管疾病而导致癒合受损的患者。再生医学领域正在解决透过开发生物工程组织和生长因子来更快、更有效地促进慢性和急性伤口癒合的治疗方法需求。

区域洞察

由于广泛的研发活动、强劲的金融投资以及政府对再生医学及相关治疗的支持政策，美洲的再生医学市场呈现显着成长。生物技术和製药领域领先公司的存在，以及组织工程和干细胞治疗的技术进步，正在促进该地区市场的强劲扩张。在强大的医疗保健系统和对再生治疗方案认识不断提高的支持下，欧洲、中东和非洲 (EMEA) 地区越来越多地采用再生医学。对干细胞研究和基因治疗的大量投资以及再生医学产品临床试验的激增进一步推动了欧洲市场的成长。由于投资和研究合作的增加，中东和非洲也逐渐增加在市场上的影响力。由于积极的政府措施、医疗成本的上升以及寻求先进治疗的患者数量的增加，亚太地区 (APAC) 的市场正在快速扩张。该地区再生医学产品研究和製造设施数量的不断增加也推动了亚太地区市场的积极前景。

FPNV定位矩阵

FPNV定位矩阵对于评估再生医学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对再生医学市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.再生医学市场的市场规模和预测是多少？

2.再生医学市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.再生医学市场的技术趋势和法规结构是什么？

4.再生医学市场主要厂商的市场占有率是多少？

5.进入再生医学市场的合适形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 更多采用干细胞技术、基因治疗和组织工程
      • 政府加大对再生医学研究的投资
      • 产品核可以及私人公司研发活动的增加
    • 抑制因素
      • 与干细胞和再生医学相关的高成本和监管问题
    • 机会
      • 再生医学生技药品的技术进步
      • 对器官和骨移植的需求增加
    • 任务
      • 有关在研究和开发中使用胚胎干细胞的伦理问题
  • 市场区隔分析
    • 类型：细胞免疫疗法和细胞治疗产品在个人化治疗中的重要应用
    • 应用：再生医学在心血管疾病的重要性日益增加
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章再生医学市场：依类型

  • 基于细胞的免疫疗法和细胞治疗产品
  • 基因治疗产品
  • 小分子/生技药品
  • 组织工程产品

第七章再生医学市场：依应用分类

  • 心血管
  • 糖尿病
  • 肌肉骨骼疾病
  • 眼科疾病
  • 肿瘤学
  • 创伤护理

第八章 北美和南美再生医学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太再生医学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲再生医学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 4DMT 的 4D-150 获得 FDA 的高级治疗指定，这是一种用于玻璃体内治疗湿性 AMD 的基因药物。
    • Sysmex 和 JCR Pharma 的合资企业 Allied Cell 收购了一条新的管道，以促进再生医疗产品的早期社会实施
    • 西乃山建立再生医学研究所
  • 战略分析和建议

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-430D42AA0F5B

[197 Pages Report] The Regenerative Medicine Market size was estimated at USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030.

Regenerative medicine is an interdisciplinary field that applies engineering and life science principles to promote regeneration, repair, or replacement of cells, tissues, or organs. It aims to restore the function of damaged or diseased tissues using a combination of approaches, including cell therapy, gene therapy, tissue engineering, and the application of biomaterials and growth factors. This rapidly evolving field holds the promise for treating various medical conditions by harnessing the body's own repair mechanisms or by creating functional tissues in the laboratory. The market for regenerative medicine is propelled by factors such as the increasing prevalence of chronic diseases and genetic disorders, advances in cellular therapy and tissue engineering, and significant investments in research and development that lead to breakthrough therapies. Additionally, the aging global population and its need for innovative regenerative treatments contribute to the expansion of the market. However, regenerative medicine faces obstacles, including stringent regulatory policies that slow down approval processes, high costs associated with therapies and research, and ethical concerns regarding stem cell use. Moreover, personalized medicine advancements open up possibilities for tailored treatments. Emerging markets are also providing new avenues for expansion, and technological innovations continue to enable better outcomes and potentially lower treatment costs over time.

KEY MARKET STATISTICS
Base Year [2023] USD 23.02 billion
Estimated Year [2024] USD 28.35 billion
Forecast Year [2030] USD 102.40 billion
CAGR (%) 23.76%

Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment

Regenerative medicine is revolutionizing the therapeutic landscape with cell-based immunotherapy and cell therapy products. These advanced therapies involve using cells to treat diseases, with allogeneic products derived from a donor and administered to multiple patients and autologous products, which are harvested from and used to treat the same individual. Gene therapy products epitomize a significant component of regenerative medicine, focusing on the direct manipulation of an organism's genes to treat or prevent disease. These therapies work by introducing, removing, or altering genetic material within a patient's cells, thereby providing a means to correct genetic abnormalities, expressing therapeutic proteins, or disabling malfunctioning genes, and have shown immense potential in the treatment of genetic disorders, certain types of cancer, and viral infections. A broad category within regenerative medicine includes small molecule and biologics. Small molecules are typically well-defined, low molecular weight compounds that can modulate biological processes, while biologics encompass a range of products such as antibodies, recombinant proteins, and peptides. These agents often act to stimulate or guide the regeneration process by influencing cellular pathways and can be particularly effective in complex tissue and organ repair. The development of tissue-engineered products is a transformative area within regenerative medicine aimed at repairing, replacing, maintaining, or enhancing the function of human tissues. Utilizing scaffolds, cells, and biologically active molecules, tissue engineering approaches meticulously design constructs that can integrate with patient tissues, offering solutions for organ shortages and providing alternatives to traditional transplants and reconstructive surgeries.

Application: Growing significance of regenerative medicines for cardiovascular diseases

Regenerative medicine offers potential treatments for cardiovascular diseases through cell therapy, tissue engineering, and gene editing to repair or replace damaged heart tissue. Preference for regenerative medicine in cardiology primarily stems from its ability to minimize invasive procedures and its promise for long-term recovery in conditions including heart failure and peripheral artery disease. Diabetes affects millions worldwide, and regenerative medicine offers the possibility of restoring insulin-producing beta cells or regenerating pancreatic tissue to treat it. There is a strong need for such innovative treatments, particularly for type 1 diabetes, where autoimmune responses destroy beta cells, and patients require lifelong insulin therapy. Musculoskeletal disorders include a wide range of conditions affecting bones, muscles, and connective tissue. Regenerative medicine applications, such as cartilage regeneration and bone repair, address the tremendous need for improved healing times and functional recovery post-injury or in the case of degenerative diseases, including osteoarthritis. Moreover, regenerative medicine can provide cell-based therapies and tissue engineering solutions to restore sight or halt disease progression and other ocular disorders. Oncology is a critical area where regenerative medicine can potentially revolutionize cancer treatment. By leveraging the body's own healing mechanisms, it can stimulate the immune system to target and destroy cancer cells. There is an increasing preference for these treatments owing to their personalized nature and their potential for fewer side effects compared to traditional therapies. Wound care is another essential component of healthcare, particularly for patients with diabetes or vascular diseases that impair healing. The field of regenerative medicine, through the development of bioengineered tissues and growth factors, addresses the need for therapies that promote faster and more effective healing of chronic and acute wounds.

Regional Insights

The regenerative medicine market in the Americas has shown significant growth with extensive research and development activities, strong financial investments, and supportive government policies for regenerative medicine and related therapies. The presence of significant players in the biotechnology and pharmaceutical sectors, coupled with technological advancements in tissue engineering and stem cell therapy, has contributed to the robust expansion of the market in this region. Europe, the Middle East, and Africa (EMEA) region exhibit a progressive adoption of regenerative medicine, backed by strong healthcare systems and rising awareness of regenerative treatment options. Europe, with substantial investments in stem cell research and gene therapy and the upsurge in clinical trials for regenerative products, has further fueled the market growth. The Middle East and Africa are also gradually expanding their market presence with increasing investments and collaborations. The Asia-Pacific (APAC) region has illustrated rapid market expansion with favorable government initiatives, rising healthcare expenditure, and a growing patient population looking for advanced treatments. The increasing number of research facilities and manufacturing units for regenerative products in this region adds to the positive outlook of the APAC market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Inc., Allergan PLC, Amgen Inc., Astellas Pharma Inc., Athersys, Inc., Bayer AG, CMIC HOLDINGS Co., LTD., Editas Medicine, Inc., FUJIFILM Cellular Dynamics, Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, JCR Pharmaceuticals Co., Ltd., Medtronic PLC, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc. by Smith & Nephew PLC, REPROCELL Inc., SanBio Company Limited, Sartorius AG, Sumitomo Pharma Co., Ltd., Sysmex Corporation, Takeda Pharmaceutical Co. Ltd., Tenaya Therapeutics, Inc., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Cell-Based Immunotherapy & Cell Therapy Products
      • Allogeneic Products
      • Autologous Products
    • Gene Therapy Products
    • Small Molecule & Biologic
    • Tissue-Engineered Products
  • Application
    • Cardiovascular
    • Diabetes
    • Musculoskeletal Disorders
    • Ocular Disorders
    • Oncology
    • Wound Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
      • 5.1.1.2. Rising government investments in regenerative medicine research
      • 5.1.1.3. Product approval coupled with increasing R&D activities by private players
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and regulatory issues pertaining to stem cell and regenerative medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in regenerative medicine biologics
      • 5.1.3.2. Growing demand for organ transplantation and bone grafting
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues related to the use of embryonic stem cells in R&D
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment
    • 5.2.2. Application: Growing significance of regenerative medicines for cardiovascular diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Regenerative Medicine Market, by Type

  • 6.1. Introduction
  • 6.2. Cell-Based Immunotherapy & Cell Therapy Products
  • 6.3. Gene Therapy Products
  • 6.4. Small Molecule & Biologic
  • 6.5. Tissue-Engineered Products

7. Regenerative Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Diabetes
  • 7.4. Musculoskeletal Disorders
  • 7.5. Ocular Disorders
  • 7.6. Oncology
  • 7.7. Wound Care

8. Americas Regenerative Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Regenerative Medicine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. 4DMT Receives FDA Regenerative Medicine Advanced Therapy Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD
    • 11.3.2. AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products
    • 11.3.3. Mount Sinai Launches Institute for Regenerative Medicine
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023